Management Team
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla convallis egestas rhoncus. Donec facilisis fermentum sem, ac viverra ante luctus vel. Donec vel mauris quam.
-
Alfred Slanetz, Ph.D.
Dr. Alfred Slanetz is the founder, president, and chief executive officer of Geneius and has been since its incorporation. He also has served as a director on Geneius’s board since…...
-
Will Liu, Ph.D.
Dr. Will Liu is a Partner of Eight Roads Ventures China, specializing in healthcare investment. Dr. Liu has twenty years of experience in the pharmaceutical and biotech industries, both in…...
-
Brian Leyland-Jones, MBBS, Ph.D.
Brian Leyland-Jones, BSc (Ist class Hons), MBBS, PhD, FRACP, FRCPC is the Chief Medical Officer of AIM-HI Accelerator Fund and the N OF 1 Mission, CSO of The Darwin Foundation,…...
Our Staff & Volunteers
Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat
- Adamu Makinwa
- Casper Lundin
- Thomas Gagné
- Christina Morgan
- Markovics Zoltán
- Jacolien Hendriks
- Isabela Barboza
- Juhani Virtanen
- Phan Châu
- Kuzey Ünal
- Juan Rubio
- Marko Mlakar
- Kelly Lambert
- Walid Ahelluc
- Ernst Graf
- Lore Smets
- Camiel de Graaf
- Ladislau Berindei
-
Alfred Slanetz, Ph.D.
Dr. Alfred Slanetz is the founder, president, and chief executive officer of Geneius and has been since its incorporation. He also has served as a director on Geneius’s board since…...
-
Will Liu, Ph.D.
Dr. Will Liu is a Partner of Eight Roads Ventures China, specializing in healthcare investment. Dr. Liu has twenty years of experience in the pharmaceutical and biotech industries, both in…...
-
Brian Leyland-Jones, MBBS, Ph.D.
Brian Leyland-Jones, BSc (Ist class Hons), MBBS, PhD, FRACP, FRCPC is the Chief Medical Officer of AIM-HI Accelerator Fund and the N OF 1 Mission, CSO of The Darwin Foundation,…...
-
Pamela Garzone, Ph.D.
Pamela Garzone, Ph.D., joined Calibr as chief medical officer in May 2019, bringing decades of clinical research experience spanning large pharmaceutical companies, biotech startups and academia. She has been responsible…...
-
Raju Kucherlapati, Ph.D.
Since 2001 Dr. Kucherlapati is the Paul C. Cabot Professor of Genetics and Professor of Medicine at Harvard Medical School and was the first Scientific Director of the Harvard Medical…...
-
WENDY W.C. LAM, Chair
Ms. Wendy Lam is a business development, fundraising, brand marketing, and client relations specialist with cross-cultural experience and fluency. She currently serves as Managing Director at Arrow Capital Limited, Hong…...
-
Eifion Phillips, Ph.D., J.D.
A medicinal chemistry scientist turned patent attorney, Dr. Eifion Phillips has helped secure his clients’ intellectual property portfolios across various fields and innovations, including those pertaining to small and large…...
-
Jia-Lu Yin
Jia-Lu Yin was born in Shanghai, China, raised in New York, New York, and educated in Cambridge, Massachusetts (Harvard University and Harvard Business School), Jia-Lu is a dedicated and personable…...
-
Kanaga Sabapathy, Ph.D.
Dr. Sabapathy obtained his Ph.D. in Molecular and Cellular Immunology from the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore, in 1995. After a post-doctoral stint at the Institute…...
-
George Tsao, Ph.D.
Professor George Tsao received his undergraduate training at the Chinese University of Hong Kong (CUHK). After graduation, he received a Shell Scholarship for Postgraduate Studies in the UK and completed…...
Join us now to make your impact
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla convallis egestas rhoncus
Donec facilisis fermentum sem, ac viverra ante luctus vel. Donec vel mauris quam.